Ontology highlight
ABSTRACT:
SUBMITTER: Hoever P
PROVIDER: S-EPMC3370822 | biostudies-literature | 2012 Jun
REPOSITORIES: biostudies-literature
Hoever P P Dorffner G G Beneš H H Penzel T T Danker-Hopfe H H Barbanoj M J MJ Pillar G G Saletu B B Polo O O Kunz D D Zeitlhofer J J Berg S S Partinen M M Bassetti C L CL Högl B B Ebrahim I O IO Holsboer-Trachsler E E Bengtsson H H Peker Y Y Hemmeter U-M UM Chiossi E E Hajak G G Dingemanse J J
Clinical pharmacology and therapeutics 20120601 6
The orexin system is a key regulator of sleep and wakefulness. In a multicenter, double-blind, randomized, placebo-controlled, two-way crossover study, 161 primary insomnia patients received either the dual orexin receptor antagonist almorexant, at 400, 200, 100, or 50 mg in consecutive stages, or placebo on treatment nights at 1-week intervals. The primary end point was sleep efficiency (SE) measured by polysomnography; secondary end points were objective latency to persistent sleep (LPS), wake ...[more]